| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |